SK

Srinivas Kodandaramaiah

Active Director Director DIN 01757196
DIN 01757196 First appointment Feb 2005 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Feb 2005
Shareholding value •••• Premium profile

About Srinivas Kodandaramaiah

Data last updated:

Srinivas Kodandaramaiah is a Director at Bioquest Solutions Private Limited (since 2005), Director at Cognitive Design Technology Private Limited (since 2008) and Designated Partner at Finaxis Advisory Llp (since 2020). The companies operate in Life Sciences, Information Technology and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹74.13 Cr; the largest is Bioquest Solutions Private Limited at ₹70.73 Cr (FY 2025). Earlier, Srinivas Kodandaramaiah was a Director at Adrena Healthcare Private Limited (from 2008) and Director at Probity Medical Research India Private Limited (from 2008).

DIN 01757196
Primary Designation Director
Industry Life Sciences
First Appointment 24 Feb 2005
Oldest Company Age 21 yrs
Largest company Bioquest Solutions Private Limited · ₹70.73 Cr (FY 2025)
Combined revenue ₹74.13 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioquest Solutions Private Limited U85110KA2005PTC035687
Director24 Feb 20052005₹70.73 Cr (FY 2025)Active
Director02 Sep 20082008₹3.39 Cr (FY 2023)Active
Designated Partner22 Jun 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adrena Healthcare Private Limited U24233KA2008PTC045387
Director25 Feb 20082008₹41.6 Lakh (FY 2016)Strike Off
Director29 Apr 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Finaxis Advisory Llp
Adrena Healthcare Private Limited
Probity Medical Research India Private Limited
Cognitive Design Technology Private Limited
Premium access

Shareholding and investment profile for Srinivas Kodandaramaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Kodandaramaiah

Srinivas Kodandaramaiah currently holds 3 directorships: Bioquest Solutions Private Limited (Director, since 24 Feb 2005, revenue ₹70.73 Cr (FY 2025)); Cognitive Design Technology Private Limited (Director, since 02 Sep 2008, revenue ₹3.39 Cr (FY 2023)); Finaxis Advisory Llp (Designated Partner, since 22 Jun 2020).

Srinivas Kodandaramaiah was first appointed on 24 Feb 2005 as Director at Bioquest Solutions Private Limited. The most recent appointment on record is 22 Jun 2020 at Finaxis Advisory Llp.

The 2 current companies of Srinivas Kodandaramaiah that report revenue have a combined latest revenue of ₹74.13 Cr: Bioquest Solutions Private Limited ₹70.73 Cr (FY 2025); Cognitive Design Technology Private Limited ₹3.39 Cr (FY 2023).

Srinivas Kodandaramaiah held 2 earlier board appointments: Adrena Healthcare Private Limited (Director, from 25 Feb 2008); Probity Medical Research India Private Limited (Director, from 29 Apr 2008).

The current boards of Srinivas Kodandaramaiah's companies include Ashish Dutt (Bioquest Solutions Private Limited), Gautam Narayan Sathia (Bioquest Solutions Private Limited), Gopinathannair Radhamma (Bioquest Solutions Private Limited), Rajesh Prabhakaran (Bioquest Solutions Private Limited), Siddhi Kaul (Bioquest Solutions Private Limited), Aravindan Ramalingam (Cognitive Design Technology Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available